Consortium
 We have established an international consortium comprising the major large scale population-based and Type 2 Diabetes (T2D) case-control studies that exist amongst South Asians. Together these studies include ~90K South Asians (~20K with T2D) from a range of differing geographic and environmental settings, including non-migrant participants from India, Pakistan, and Sri Lanka, and migrant populations from the UK, the USA, Singapore and Mauritius. All participating cohorts have extensive clinical characterisation as well as samples of plasma and DNA for future molecular studies.
Key partner strengths
|
|
|
EpiMigrant: Identification of epigenetic markers underlying increased risk of Type 2 diabetes in South Asians.
Funding scheme: Specific International Cooperation Action (SICA), Collaborative Project.
Work programme topics: HEALTH.2011.2.4.3-4 Genetic and environmental factors in obesity and/or diabetes in specific populations.
Project Investigator: Dr John Chambers, Imperial College London.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 279143.